Patents by Inventor Truc Thi Kim Thanh Hoang

Truc Thi Kim Thanh Hoang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • M.tuberculosis vaccines
    Patent number: 10004793
    Abstract: The present invention is directed to a fusion protein, antigen cocktails and immunological compositions such as vaccines against infections caused by virulent mycobacteria, e.g. by Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium microti, Mycobacterium canettii, Mycobacterium pinnipedii or Mycobacterium mungi. The fusion protein, antigen cocktails and immunological compositions are based on proteins secreted by the ESAT-6 secretion system 1 (ESX-1) and are among the most immunodominant M. tuberculosis (MTB) antigens.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: June 26, 2018
    Assignee: Statens Serum Institut
    Inventors: Claus Aagaard, Ida Rosenkrands, Truc Thi Kim Thanh Hoang, Peter Lawaetz Andersen
  • NEW M.TUBERCULOSIS VACCINES
    Publication number: 20170043003
    Abstract: The present invention is directed to a fusion protein, antigen cocktails and immunological compositions such as vaccines against infections caused by virulent mycobacteria, e.g. by Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium microti, Mycobacterium canettii, Mycobacterium pinnipedii or Mycobacterium mungi. The fusion protein, antigen cocktails and immunological compositions are based on proteins secreted by the ESAT-6 secretion system 1 (ESX-1) and are among the most immunodominant M. tuberculosis (MTB) antigens.
    Type: Application
    Filed: April 9, 2015
    Publication date: February 16, 2017
    Inventors: Claus Aagaard, Ida Rosenkrands, Truc Thi Kim Thanh Hoang, Peter Lawaetz Andersen
  • vaccines
    Patent number: 9526773
    Abstract: The present invention is directed to fusion proteins, antigen cocktails and immunological compositions such as vaccines against infections caused by virulent mycobacteria, e.g. by Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium microti, Mycobacterium canettii, Mycobacterium pinnipedii or Mycobacterium mungi. The fusion proteins or antigen cocktails are based on ESX secreted or associated proteins e.g. proteins secreted by the ESAT-6 secretion system 1 (ESX-1) which are among the most immunodominant M. tuberculosis (MTB) antigens.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: December 27, 2016
    Assignee: Statens Serum Institut
    Inventors: Claus Aagaard, Ida Rosenkrands, Truc Thi Kim Thanh Hoang, Peter Andersen
  • M. TUBERCULOSIS VACCINES
    Publication number: 20150290311
    Abstract: The present invention is directed to fusion proteins, antigen cocktails and immunological compositions such as vaccines against infections caused by virulent mycobacteria, e.g. by Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis, Mycobacterium microti, Mycobacterium canettii, Mycobacterium pinnipedii or Mycobacterium mungi. The fusion proteins or antigen cocktails are based on ESX secreted or associated proteins e.g. proteins secreted by the ESAT-6 secretion system 1 (ESX-1) which are among the most immunodominant M. tuberculosis (MTB) antigens.
    Type: Application
    Filed: October 18, 2013
    Publication date: October 15, 2015
    Inventors: Claus Aagaard, Ida Rosenkrands, Truc Thi Kim Thanh Hoang, Peter Andersen